BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32185874)

  • 1. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lung allograft dysfunction: evolving practice.
    Vos R; Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
    Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
    Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
    DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
    Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
    Sato M
    Ann Transl Med; 2020 Mar; 8(6):418. PubMed ID: 32355862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
    Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
    Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
    Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
    Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
    Iasella CJ; Hoji A; Popescu I; Wei J; Snyder ME; Zhang Y; Xu W; Iouchmanov V; Koshy R; Brown M; Fung M; Langelier C; Lendermon EA; Dugger D; Shah R; Lee J; Johnson B; Golden J; Leard LE; Ellen Kleinhenz M; Kilaru S; Hays SR; Singer JP; Sanchez PG; Morrell MR; Pilewski JM; Greenland JR; Chen K; McDyer JF
    Am J Transplant; 2021 Jun; 21(6):2145-2160. PubMed ID: 33078555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
    Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
    Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.